Pages that link to "Q106875739"
Jump to navigation
Jump to search
The following pages link to hypermethylation (Q106875739):
Displaying 50 items.
- A physical, transcript, and deletion map of chromosome region 12p12.3 flanked by ETV6 and CDKN1B: hypermethylation of the LRP6 CpG island in two leukemia patients with hemizygous del(12p) (Q28137717) (← links)
- Frequent hypermethylation of the hMLH1 gene promoter in differentiated-type tumors of the stomach with the gastric foveolar phenotype (Q28138184) (← links)
- Hypermethylation-associated inactivation of p14(ARF) is independent of p16(INK4a) methylation and p53 mutational status (Q28143274) (← links)
- Hypermethylation of multiple genes in tumor tissues and voided urine in urinary bladder cancer patients (Q28156141) (← links)
- Silencing of the p18INK4c gene by promoter hypermethylation in Reed-Sternberg cells in Hodgkin lymphomas (Q28188054) (← links)
- Hypermethylation and histone deacetylation lead to silencing of the maspin gene in human breast cancer (Q28200804) (← links)
- Hypermethylation of the TSLC1 Gene Promoter in Primary Gastric Cancers and Gastric Cancer Cell Lines (Q28201307) (← links)
- Frequent hypermethylation of the 5' CpG island of the mitotic stress checkpoint gene Chfr in colorectal and non-small cell lung cancer (Q28204269) (← links)
- A proapoptotic caspase recruitment domain protein gene, TMS1, is hypermethylated in human breast and gastric cancers (Q28205419) (← links)
- Chfr expression is downregulated by CpG island hypermethylation in esophageal cancer (Q28206993) (← links)
- Hypermethylation in human cancers of the RIZ1 tumor suppressor gene, a member of a histone/protein methyltransferase superfamily (Q28207095) (← links)
- O(6)-Methylguanine-DNA methyltransferase promoter hypermethylation shifts the p53 mutational spectrum in non-small cell lung cancer (Q28207119) (← links)
- Hypermethylation of HPP1 is associated with hMLH1 hypermethylation in gastric adenocarcinomas (Q28207997) (← links)
- A gene hypermethylation profile of human cancer (Q28213253) (← links)
- Analysis of 11q21-24 loss of heterozygosity candidate target genes in breast cancer: indications of TSLC1 promoter hypermethylation (Q28214329) (← links)
- Aberrant hypermethylation of the CHFR prophase checkpoint gene in human lung cancers (Q28214439) (← links)
- Inactivation of p57KIP2 by regional promoter hypermethylation and histone deacetylation in human tumors (Q28215348) (← links)
- Reduced expression of insulin-like growth factor binding protein-3 and its promoter hypermethylation in human hepatocellular carcinoma (Q28216191) (← links)
- Hypermethylation of gene promoters in hematological neoplasia (Q28216777) (← links)
- Reduced expression of the REIC/Dkk-3 gene by promoter-hypermethylation in human tumor cells (Q28216816) (← links)
- Methyltransferase recruitment and DNA hypermethylation of target promoters by an oncogenic transcription factor (Q28217975) (← links)
- Identification of tumour-specific epigenetic events in medulloblastoma development by hypermethylation profiling (Q28235362) (← links)
- Hepatocyte growth factor activator inhibitor 2/placental bikunin (HAI-2/PB) gene is frequently hypermethylated in human hepatocellular carcinoma (Q28236057) (← links)
- Down-regulation of LATS1 and LATS2 mRNA expression by promoter hypermethylation and its association with biologically aggressive phenotype in human breast cancers (Q28237942) (← links)
- Downregulated mRNA expression of ASPP and the hypermethylation of the 5'-untranslated region in cancer cell lines retaining wild-type p53 (Q28238984) (← links)
- Frequent inactivation of RAMP2, EFEMP1 and Dutt1 in lung cancer by promoter hypermethylation (Q28239043) (← links)
- Promoter hypermethylation silences expression of the HoxA4 gene and correlates with IgVh mutational status in CLL (Q28239532) (← links)
- Microsatellite instability and promoter hypermethylation of MLH1 and MSH2 in patients with sporadic colorectal cancer (Q28243503) (← links)
- Abrogation of DUSP6 by hypermethylation in human pancreatic cancer (Q28244702) (← links)
- Hypermethylated SUPERMAN epigenetic alleles in arabidopsis (Q28246520) (← links)
- Detection of bladder cancer in urine by a tumor suppressor gene hypermethylation panel (Q28252481) (← links)
- MSH2 promoter hypermethylation in circulating tumor DNA is a valuable predictor of disease-free survival for patients with esophageal squamous cell carcinoma (Q28257837) (← links)
- Promoter hypermethylation of FANCF: disruption of Fanconi Anemia-BRCA pathway in cervical cancer (Q28260207) (← links)
- Transcriptional silencing of secreted frizzled related protein 1 (SFRP 1) by promoter hypermethylation in non-small-cell lung cancer (Q28260824) (← links)
- Promoter hypermethylation mediates downregulation of thiamine receptor SLC19A3 in gastric cancer (Q28261011) (← links)
- Promoter hypermethylation is the predominant mechanism in hMLH1 and hMSH2 deregulation and is a poor prognostic factor in nonsmoking lung cancer (Q28265168) (← links)
- Promoter-hypermethylation is causing functional relevant downregulation of methylthioadenosine phosphorylase (MTAP) expression in hepatocellular carcinoma (Q28265788) (← links)
- Deleted in colorectal cancer is a putative conditional tumor-suppressor gene inactivated by promoter hypermethylation in head and neck squamous cell carcinoma (Q28266809) (← links)
- Promoter hypermethylation and silencing of CHFR mitotic stress checkpoint gene in human gastric cancers (Q28267308) (← links)
- ADAM23, a possible tumor suppressor gene, is frequently silenced in gastric cancers by homozygous deletion or aberrant promoter hypermethylation (Q28267600) (← links)
- Promoter hypermethylation-mediated down-regulation of LATS1 and LATS2 in human astrocytoma (Q28269109) (← links)
- Promoter Hypermethylation of FANCF and Susceptibility and Prognosis of Epithelial Ovarian Cancer (Q28269159) (← links)
- Discovery and Validation of Hypermethylated Markers for Colorectal Cancer (Q28277670) (← links)
- DNA hypermethylation status of multiple genes in soft tissue sarcomas (Q28279569) (← links)
- Identification of the p53 family-responsive element in the promoter region of the tumor suppressor gene hypermethylated in cancer 1 (Q28283017) (← links)
- CpG island promoter hypermethylation of the Ras-effector gene NORE1A occurs in the context of a wild-type K-ras in lung cancer (Q28283044) (← links)
- Inactivation of human mutL homolog 1 and mutS homolog 2 genes in head and neck squamous cell carcinoma tumors and leukoplakia samples by promoter hypermethylation and its relation with microsatellite instability phenotype (Q28283091) (← links)
- Promoter hypermethylation of ARID1A gene is responsible for its low mRNA expression in many invasive breast cancers (Q28284179) (← links)
- Silencing of the retinoid response gene TIG1 by promoter hypermethylation in nasopharyngeal carcinoma (Q28285236) (← links)
- MLH1 promoter hypermethylation is associated with the microsatellite instability phenotype in sporadic endometrial carcinomas (Q28288475) (← links)